CSPC Pharmaceutical Group Limited
HKSE: 1093.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Lei Cai
- Employees
- 21,400
- Headquarters
- Shijiazhuang, China
- IPO year
- 1994
- Market cap
- HK$93.5B
- Website
- https://www.cspc.com.hk
Loading 1093…
Loading profile data…Frequently asked questions about 1093
What does CSPC Pharmaceutical Group Limited (1093.HK) do?
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, the Americas, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others s...
Where does 1093.HK trade?
CSPC Pharmaceutical Group Limited (1093.HK) trades on the Hong Kong Stock Exchange.
What sector is 1093.HK in?
CSPC Pharmaceutical Group Limited (1093.HK) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of CSPC Pharmaceutical Group Limited?
Lei Cai is the chief executive officer of CSPC Pharmaceutical Group Limited (1093.HK).
Where is CSPC Pharmaceutical Group Limited headquartered?
CSPC Pharmaceutical Group Limited is headquartered in China.
Does 1093.HK pay a dividend?
Yes — CSPC Pharmaceutical Group Limited (1093.HK) paid a trailing twelve-month dividend of HKD 0.30 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 1093.HK go public?
CSPC Pharmaceutical Group Limited (1093.HK) completed its initial public offering in 1994.